Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Pharmacology
|
April 13, 2000
Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation
N B Modi, B Lindemulder, S K Gupta
Journal of Clinical Pharmacology
|
October 4, 2008
Effect of dapoxetine on the pharmacokinetics and hemodynamic effects of tamsulosin in men on a stable dose of tamsulosin
N B Modi, S Kell, J Aquilina, et al.
Biopharmaceutics & Drug Disposition
|
March 25, 1998
Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: a comparison of three dosing regimens
S Eppler, T Senn, E Gilkerson, et al.
Journal of Clinical Pharmacology
|
October 12, 2000
Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system
N B Modi, B Wang, R J Noveck, et al.
Biopharmaceutics & Drug Disposition
|
October 20, 2000
Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects
N B Modi, B Wang, W T Hu, et al.
Biopharmaceutics & Drug Disposition
|
August 22, 2001
Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications
N B Modi, A Lam, E Lindemulder, et al.
Journal of Pharmaceutical Sciences
|
July 1, 1993
Application of a system analysis approach to population pharmacokinetics and pharmacodynamics of nicardipine hydrochloride in healthy males
N B Modi, P Veng-Pedersen, D J Graham, et al.
Journal of Clinical Pharmacology
|
July 7, 1999
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb/IIIa antagonist, in patients with acute coronary syndrome
N B Modi, W Novotny, J D Reimann, et al.
International Journal of Impotence Research
|
November 25, 2005
Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors
M J Dresser, D Desai, S Gidwani, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 10, 2005
Metabolism of [3H]pentosan polysulfate sodium (PPS) in healthy human volunteers
M Simon, R H McClanahan, J F Shah, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Pharmacology
|
April 13, 2000
Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation
N B Modi, B Lindemulder, S K Gupta
Journal of Clinical Pharmacology
|
October 4, 2008
Effect of dapoxetine on the pharmacokinetics and hemodynamic effects of tamsulosin in men on a stable dose of tamsulosin
N B Modi, S Kell, J Aquilina, et al.
Biopharmaceutics & Drug Disposition
|
March 25, 1998
Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: a comparison of three dosing regimens
S Eppler, T Senn, E Gilkerson, et al.
Journal of Clinical Pharmacology
|
October 12, 2000
Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system
N B Modi, B Wang, R J Noveck, et al.
Biopharmaceutics & Drug Disposition
|
October 20, 2000
Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects
N B Modi, B Wang, W T Hu, et al.
Biopharmaceutics & Drug Disposition
|
August 22, 2001
Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications
N B Modi, A Lam, E Lindemulder, et al.
Journal of Pharmaceutical Sciences
|
July 1, 1993
Application of a system analysis approach to population pharmacokinetics and pharmacodynamics of nicardipine hydrochloride in healthy males
N B Modi, P Veng-Pedersen, D J Graham, et al.
Journal of Clinical Pharmacology
|
July 7, 1999
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb/IIIa antagonist, in patients with acute coronary syndrome
N B Modi, W Novotny, J D Reimann, et al.
International Journal of Impotence Research
|
November 25, 2005
Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors
M J Dresser, D Desai, S Gidwani, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 10, 2005
Metabolism of [3H]pentosan polysulfate sodium (PPS) in healthy human volunteers
M Simon, R H McClanahan, J F Shah, et al.
Page
of 4